Cartesian Growth IV Q2 net loss narrows to $23,822
Reuters2026/08/12 20:32- Cartesian Growth Corporation IV posted a net loss of USD 23,822 for the three months ended June 30, 2026.
- Operating loss totaled USD 77,949, partly offset by USD 54,127 of interest income from investments held in the Trust Account.
- Since inception on Feb. 20, 2026 through June 30, 2026, net loss was USD 40,752.
- The SPAC raised USD 275 million in gross IPO proceeds, adding USD 5 million from private placement warrants.
- Trust Account investments stood at USD 275.05 million as of June 30, 2026, invested in U.S. Treasury bills with maturities of 185 days or less.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

10-Yr Benchmark Govt Yields - Germany vs Other Nations